Sign Up to like & get
recommendations!
0
Published in 2018 at "American Journal of Hematology"
DOI: 10.1002/ajh.25225
Abstract: Busulfan plus cyclophosphamide (BuCy) is the traditional conditioning regimen for allogeneic stem cell transplant (allo‐SCT) for young, fit patients with acute myeloid leukemia (AML). The thiotepa‐busulfan‐fludarabine (TBF) protocol has recently demonstrated promising outcome in cord…
read more here.
Keywords:
busulfan;
regimen allogeneic;
transplant;
conditioning regimen ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Annals of Hematology"
DOI: 10.1007/s00277-020-04312-y
Abstract: Busulfan and cyclophosphamide (BuCy) is a frequently used myeloablative conditioning regimen for allogeneic hematopoietic cell transplantation (allo-HCT). Theoretical considerations and pharmacological data indicate that application of busulfan prior to subsequent cyclophosphamide (BuCy) may trigger liver…
read more here.
Keywords:
busulfan;
regimen allogeneic;
allogeneic hematopoietic;
conditioning regimen ... See more keywords